The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinico-transcriptomic risk stratification to guide abiraterone treatment intensification in high-risk prostate cancer: A combined analysis of NRG/RTOG 9202, 9413, 9902, and 0521.
 
Krishnan Patel
No Relationships to Disclose
 
Eli Rosenbaum
No Relationships to Disclose
 
Marla Johnson
Employment - Veracyte
 
Hyunnam Ryu
Employment - Veracyte
 
James Proudfoot
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
 
Elai Davicioni
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
Patents, Royalties, Other Intellectual Property - WO2018205035A1 Decipher prostate cancer genomic classifier gene signature patent- assigned to my employer Veracyte
 
Daniel Spratt
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Novartis; Pfizer
(OPTIONAL) Uncompensated Relationships - NCCN
 
Howard Sandler
Consulting or Advisory Role - Janssen
(OPTIONAL) Uncompensated Relationships - American Society for Radiation Oncology
 
Mack Roach
Honoraria - NYU Long Island School of Medicine / NYU Langone Health
Consulting or Advisory Role - Accuray
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - UniBanco Brasil
 
Seth Rosenthal
No Relationships to Disclose
 
Adam Dicker
Stock and Other Ownership Interests - Oncohost
Consulting or Advisory Role - CVS; Janssen; Oncohost
Patents, Royalties, Other Intellectual Property - We recently filed a patient "DOPED BEO COMPOUNDS FOR OPTICALLY STIMULATED LUMINESCENCE (OSL) AND THERMOLUMINESCENCE (TL) RADIATION DOSIMETRY" (Inst)
Travel, Accommodations, Expenses - Oncohost
 
Nirav Kapadia
No Relationships to Disclose
 
Rohann Correa
No Relationships to Disclose
 
Fan Zhu
No Relationships to Disclose
 
Samir Patel
No Relationships to Disclose
 
Comron Hassanzadeh
No Relationships to Disclose
 
Jason Efstathiou
Honoraria - Elekta; IBA
Consulting or Advisory Role - AngioDynamics; AstraZeneca; Bayer; Bioprotect; Blue Earth Diagnostics; Blue Earth Diagnostics; Boston Scientific; Clarity Pharmaceuticals; Genentech; Gilead Sciences; Janssen; Johnson & Johnson/Janssen; Lantheus Medical Imaging; MDxHealth; Merck; Myovant Sciences; Pfizer; Progenics
 
Stephanie Pugh
Research Funding - Janssen (Inst); Novartis (Inst); Pfizer (Inst)
 
Paul Nguyen
Stock and Other Ownership Interests - Nanocan Therapeutics; Reversal Therapeutics; Stratagen Bio; Telerad Oncology; Volatilyx (I)
Consulting or Advisory Role - AIQ Solutions; Amgen; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Myovant Sciences; Nanocan Therapeutics; Novartis; Theranano
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
 
Phuoc Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Dendreon; GenomeDx; Janssen; Lantheus Medical Imaging; Myovant Sciences; Novartis; Noxopharm; Pfizer; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical